EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Basigin in cerebrovascular diseases: Roles, mechanisms, and therapeutic target potential

Qi Qin, Mengzhao Feng, Kaiyuan Zhang, Zhizhun Mo, Yuxiang Liu, Yinzhong Ma, Xianzhi Liu

European Journal of Pharmacology · 2025

DOI: 10.1016/j.ejphar.2024.177232 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Pharmacology, 2025. Verfasst von Qi Qin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Zhengzhou City, Henan Province, 450000, Ch…. Hauptthemen laut MEDLINE: Basigin, Cerebrovascular Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 122 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science, Technology and Innovation Commission of Shenzhen Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebrovascular diseases are major global health issues, responsible for significant morbidity and mortality. Basigin (additionally called CD147 or EMMPRIN) is a glycosylated transmembrane protein that facilitates intercellular communication. Recent research has highlighted the critical role of Basigin in inducing matrix metalloproteinases (MMPs), which contribute to the progression of cerebrovascular diseases. Consequently, Basigin has emerged as a promising therapeutic target for these conditions. However, inhibiting the pivotal role of Basigin in mediating cerebrovascular disease is an urgent area of investigation. In this review, we systematically examine the pathological mechanisms by which Basigin contributes to the development of cerebrovascular diseases. We present evidence demonstrating the protective effect of targeted inhibition of Basigin in these conditions and suggest future research directions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BasiginCerebrovascular DisordersHumansAnimalsMolecular Targeted TherapyMatrix Metalloproteinases

Stichwörter der Autor:innen

BasiginCD147Cerebrovascular diseasesIntracerebral hemorrhageStroke

Substanzen

BasiginMatrix Metalloproteinases

Autor:innen und Institutionen

  • Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Zhengzhou City, Henan Province, 450000, China.
  • Emergency Department, Shenzhen Traditional Chinese Medicine Hospital, The fourth Clinical Medical College of Guangzhou University of Chinese Medicine, No.1 Fuhua Road, Shenzhen City, Guangdong Province, 518033, China.
  • Institute of Medicine, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Avenue, Nanshan District, Shenzhen City, Guangdong Province, 518055, China. Electronic address: yz.ma@siat.ac.c…
  • Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Zhengzhou City, Henan Province, 450000, China. Electronic address: fccliuxz@zzu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Science, Technology and Innovation Commission of Shenzhen Municipality

Zitieren

APA

Qin, Q., Feng, M., Zhang, K., Mo, Z., Liu, Y., Ma, Y., & Liu, X. (2025). Basigin in cerebrovascular diseases: Roles, mechanisms, and therapeutic target potential. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2024.177232

Vancouver

Qin Q, Feng M, Zhang K, Mo Z, Liu Y, Ma Y, et al. Basigin in cerebrovascular diseases: Roles, mechanisms, and therapeutic target potential. European Journal of Pharmacology. 2025. doi:10.1016/j.ejphar.2024.177232

BibTeX
@article{Qin2025,
  author = {Qin, Qi and Feng, Mengzhao and Zhang, Kaiyuan and Mo, Zhizhun and Liu, Yuxiang and Ma, Yinzhong and Liu, Xianzhi},
  title = {Basigin in cerebrovascular diseases: Roles, mechanisms, and therapeutic target potential},
  journal = {European Journal of Pharmacology},
  year = {2025},
  doi = {10.1016/j.ejphar.2024.177232}
}
Kostenlos starten →